clinical trials of Novavax's Covid-19 vaccine 'Covovax' on children in July. The SII is also planning to introduce 'Covovax' -- its version of the US firm Novavax's vaccine candidate -- in India by September.Last year in September, Novavax had announced a manufacturing agreement with SII for its Covid-19 vaccine NVX-CoV2373."Covovax trials finally begin in India; the vaccine is made through a partnership with @Novavax and @SerumInstIndia.
It has been tested against African and UK variants of #COVID19 and has an overall efficacy of 89%. Hope to launch by September 2021!," SII CEO Adar Poonawalla had announced on Twitter.The Indian Government is also keen on the Pune-based vaccine manufacturer starting a trial of the Covovax vaccine in.